Dyne Therapeutics (DYN)
(Real Time Quote from BATS)
$44.12 USD
+0.93 (2.15%)
Updated Jul 23, 2024 03:52 PM ET
After-Market: $43.99 -0.13 (-0.29%) 4:14 PM ET
2-Buy of 5 2
D Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | -0.72 |
EPS Last Quarter | -0.81 |
Last EPS Surprise | 0.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.00 |
Next Year | -3.06 |
EPS (TTM) | -3.97 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 127.39M |
# of Estimates | NA | NA | NA | 1 |
High Estimate | NA | NA | NA | 127.39M |
Low Estimate | NA | NA | NA | 127.39M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.72 | -0.74 | -3.00 | -3.06 |
# of Estimates | 8 | 8 | 9 | 9 |
Most Recent Consensus | -0.64 | -0.65 | -2.63 | -2.50 |
High Estimate | -0.59 | -0.60 | -2.63 | -1.41 |
Low Estimate | -0.97 | -1.03 | -3.81 | -3.99 |
Year ago EPS | -1.08 | -0.99 | -3.95 | -3.00 |
Year over Year Growth Est. | 33.33% | 25.25% | 24.05% | -1.93% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 2 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.72 | -0.74 | -3.00 | -3.06 |
7 Days Ago | -0.72 | -0.74 | -3.00 | -3.06 |
30 Days Ago | -0.72 | -0.74 | -3.00 | -3.06 |
60 Days Ago | -0.73 | -0.76 | -3.08 | -3.13 |
90 Days Ago | -0.79 | -0.81 | -3.13 | -3.14 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.72 | -0.74 | -3.00 | -2.29 |
Zacks Consensus Estimate | -0.72 | -0.74 | -3.00 | -3.06 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 25.22% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.81 | -1.09 | -0.99 | -1.08 | NA |
Estimate | -0.81 | -0.92 | -0.86 | -0.81 | NA |
Difference | 0.00 | -0.17 | -0.13 | -0.27 | -0.14 |
Surprise | 0.00% | -18.48% | -15.12% | -33.33% | -16.73% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more